ALKS (US) share price forecast & AI signal — Alkermes plc
Week of 2026-10-30 · Healthcare
Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.
Get 5 free tokens — no card Already a member? Open the full analysisWhat the model sees in ALKS
Alkermes plc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a BUY with low confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.
About Alkermes plc
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the...
Recent closes
| Date | Close |
|---|---|
| 2026-11-06 | $45.90 |
| 2026-11-05 | $44.54 |
| 2026-11-04 | $45.89 |
| 2026-11-03 | $45.69 |
| 2026-11-02 | $44.89 |
| 2026-10-30 | $45.34 |
| 2026-10-29 | $45.37 |
ALKS FAQ
Is Alkermes plc (ALKS) a buy or sell this week?
The ACE Stock Bots machine-learning model rates ALKS a BUY for the week of 2026-10-30 with low confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).
What is the AI share price forecast for ALKS?
Every week the model scores ALKS across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.
Is this financial advice?
No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.
Other Healthcare stocks on the US
This week's top US picks · All US stocks
Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.